Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Dranse, Helen J ^a   Waise, T M Zaved ^a   Hamr, Sophie C ^a,b   Bauer, Paige V ^a,b   Abraham, Mona A ^a,b   Rasmussen, Brittany A ^a,b   Lam, Tony K T ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CASEIN HYDROLYSATE; GLUCAGON; GLUCOSE; INSULIN; PEPTIDE TRANSPORTER 1; CASEIN; SLC15A1 PROTEIN, RAT;

AMINO ACID; GLUCOSE; HOMEOSTASIS; HORMONE; OBESITY; PEPTIDE; PHYSIOLOGICAL RESPONSE; PROTEIN; TOLERANCE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FAT MASS; FOOD INTAKE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN LEVEL; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; RAT; SMALL INTESTINE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; ENZYMOLOGY; HYPERGLYCEMIA; INTESTINE ABSORPTION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; PROTEIN DIET; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT;

RATTUS; RODENTIA;

AMINO ACIDS; ANIMALS; CASEINS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-PROTEIN; GLUCOSE; HYPERGLYCEMIA; INSULIN; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; PEPTIDE TRANSPORTER 1; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85044241690     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-03490-8     Document Type: Article

References (70)

1. World Health Organization. Global Report on Diabetes. Available at http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257-eng.pdf (World Health Organization, Geneva, 2016).
2. Arciero, P. J. et al. Moderate protein intake improves total and regional body composition and insulin sensitivity in overweight adults. Metabolism 57, 757-765 (2008).
3. Boden, G., Sargrad, K., Homko, C., Mozzoli, M. & Stein, T. P. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann. Intern. Med. 142, 403-411 (2005).
4. Lacroix, M. et al. A long-Term high-protein diet markedly reduces adipose tissue without major side effects in Wistar male rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R934-R942 (2004).
5. Pichon, L., Huneau, J. F., Fromentin, G. & Tome, D. A high-protein, high-fat, carbohydrate-free diet reduces energy intake, hepatic lipogenesis, and adiposity in rats. J. Nutr. 136, 1256-1260 (2006).
6. Skov, A. R., Toubro, S., Ronn, B., Holm, L. & Astrup, A. Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J. Obes. Relat. Metab. Disord. 23, 528-536 (1999).
7. Gannon, M. C., Nuttall, F. Q., Saeed, A., Jordan, K. & Hoover, H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am. J. Clin. Nutr. 78, 734-741 (2003).
8. Blouet, C. et al. The reduced energy intake of rats fed a high-protein low-carbohydrate diet explains the lower fat deposition, but macronutrient substitution accounts for the improved glycemic control. J. Nutr. 136, 1849-1854 (2006).
9. Calbet, J. A. & MacLean, D. A. Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J. Nutr. 132, 2174-2182 (2002).
10. Claessens, M., Calame, W., Siemensma, A. D., van Baak, M. A. & Saris, W. H. The effect of different protein hydrolysate/carbohydrate mixtures on postprandial glucagon and insulin responses in healthy subjects. Eur. J. Clin. Nutr. 63, 48-56 (2009).
11. Day, J. L. et al. Factors governing insulin and glucagon responses during normal meals. Clin. Endocrinol. 9, 443-454 (1978).
12. Gannon, M. C. & Nuttall, F. Q. Acute effects of ingestion of carbohydrate, protein, or fat on cardiac glycogen metabolism in rats. Metabolism 36, 595-600 (1987).
13. LaPierre, M. P., Abraham, M. A., Yue, J. T., Filippi, B. M. & Lam, T. K. Glucagon signalling in the dorsal vagal complex is sufficient and necessary for high-protein feeding to regulate glucose homeostasis in vivo. EMBO Rep. 16, 1299-1307 (2015).
14. Pillot, B., Soty, M., Gautier-Stein, A., Zitoun, C. & Mithieux, G. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. Endocrinology 150, 616-624 (2009).
15. Gannon, M. C. & Nuttall, F. Q. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53, 2375-2382 (2004).
16. Gannon, M. C., Nuttall, F. Q., Neil, B. J. & Westphal, S. A. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 37, 1081-1088 (1988).
17. Manders, R. J. et al. Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am. J. Clin. Nutr. 82, 76-83 (2005).
18. Nuttall, F. Q., Mooradian, A. D., Gannon, M. C., Billington, C. & Krezowski, P. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 7, 465-470 (1984).
19. Akhavan, T., Luhovyy, B. L., Brown, P. H., Cho, C. E. & Anderson, G. H. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am. J. Clin. Nutr. 91, 966-975 (2010).
20. Gunnerud, U. J., Heinzle, C., Holst, J. J., Ostman, E. M. & Bjorck, I. M. Effects of pre-meal drinks with protein and amino acids on glycemic and metabolic responses at a subsequent composite meal. PLoS ONE 7, e44731 (2012).
21. Ryan, A. T. et al. Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men. Am. J. Clin. Nutr. 98, 300-311 (2013).
22. Steinert, R. E. et al. Effects of intraduodenal infusion of L-Tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men. J. Clin. Endocrinol. Metab. 99, 3275-3284 (2014).
23. Cordier-Bussat, M. et al. Peptones stimulate cholecystokinin secretion and gene transcription in the intestinal cell line STC-1. Endocrinology 138, 1137-1144 (1997).
24. Cordier-Bussat, M. et al. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes 47, 1038-1045 (1998).
25. Diakogiannaki, E. et al. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia 56, 2688-2696 (2013).
26. Pais, R., Gribble, F. M. & Reimann, F. Signalling pathways involved in the detection of peptones by murine small intestinal enteroendocrine L-cells. Peptides 77, 9-15 (2016).
27. Bowen, J., Noakes, M. & Clifton, P. M. Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake. J. Clin. Endocrinol. Metab. 91, 2913-2919 (2006).
28. Lejeune, M. P., Westerterp, K. R., Adam, T. C., Luscombe-Marsh, N. D. & Westerterp-Plantenga, M. S. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am. J. Clin. Nutr. 83, 89-94 (2006).
29. van der Klaauw, A. A. et al. High protein intake stimulates postprandial GLP1 and PYY release. Obes. 21, 1602-1607 (2013).
30. Darcel, N. P., Liou, A. P., Tome, D. & Raybould, H. E. Activation of vagal afferents in the rat duodenum by protein digests requires PepT1. J. Nutr. 135, 1491-1495 (2005).
31. Eastwood, C., Maubach, K., Kirkup, A. J. & Grundy, D. The role of endogenous cholecystokinin in the sensory transduction of luminal nutrient signals in the rat jejunum. Neurosci. Lett. 254, 145-148 (1998).
32. Faipoux, R., Tome, D., Gougis, S., Darcel, N. & Fromentin, G. Proteins activate satiety-related neuronal pathways in the brainstem and hypothalamus of rats. J. Nutr. 138, 1172-1178 (2008).
33. Groneberg, D. A., Doring, F., Eynott, P. R., Fischer, A. & Daniel, H. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G697-G704 (2001).
34. Matsumura, K., Miki, T., Jhomori, T., Gonoi, T. & Seino, S. Possible role of PEPT1 in gastrointestinal hormone secretion. Biochem. Biophys. Res. Commun. 336, 1028-1032 (2005).
35. Zietek, T., Rath, E., Haller, D. & Daniel, H. Intestinal organoids for assessing nutrient transport, sensing and incretin secretion. Sci. Rep. 5, 16831 (2015).
36. McConnell, E. L., Basit, A. W. & Murdan, S. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J. Pharm. Pharmacol. 60, 63-70 (2008).
37. Tremblay, F. et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54, 2674-2684 (2005).
38. Tremblay, F. & Marette, A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J. Biol. Chem. 276, 38052-38060 (2001).
39. Wang, P. Y. et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452, 1012-1016 (2008).
40. Meredith, D. et al. 4-Aminomethylbenzoic acid is a non-Translocated competitive inhibitor of the epithelial peptide transporter PepT1. J. Physiol. 512, 629-634 (1998).
41. Yue, J. T. et al. Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity. Nat. Commun. 7, 13501 (2016).
42. Cote, C. D. et al. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nat. Med. 21, 498-505 (2015).
43. Duca, F. A. et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21, 506-511 (2015).
44. Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest 122, 153-162 (2012).
45. Samuel, V. T. et al. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with type 2 diabetes. Proc. Natl. Acad. Sci. USA 106, 12121-12126 (2009).
46. Karamanlis, A. et al. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am. J. Clin. Nutr. 86, 1364-1368 (2007).
47. Duraffourd, C. et al. Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell 150, 377-388 (2012).
48. Duca, F. A., Bauer, P. V., Hamr, S. C. & Lam, T. K. Glucoregulatory relevance of small intestinal nutrient sensing in physiology, bariatric surgery, and pharmacology. Cell Metab. 22, 367-380 (2015).
49. Rasmussen, B. A. et al. Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. Gastroenterology 142, 834-843.e833 (2012).
50. Batterham, R. L. et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 4, 223-233 (2006).
51. Fei, Y. J. et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368, 563-566 (1994).
52. Erickson, R. H., Gum, J. R. Jr., Lindstrom, M. M., McKean, D. & Kim, Y. S. Regional expression and dietary regulation of rat small intestinal peptide and amino acid transporter mRNAs. Biochem. Biophys. Res. Commun. 216, 249-257 (1995).
53. Ihara, T., Tsujikawa, T., Fujiyama, Y. & Bamba, T. Regulation of PepT1 peptide transporter expression in the rat small intestine under malnourished conditions. Digestion 61, 59-67 (2000).
54. Thamotharan, M., Bawani, S. Z., Zhou, X. & Adibi, S. A. Functional and molecular expression of intestinal oligopeptide transporter (Pept-1) after a brief fast. Metabolism 48, 681-684 (1999).
55. Nassl, A. M. et al. Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G128-G137 (2011).
56. Chu, X. Y. et al. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter. J. Pharmacol. Exp. Ther. 299, 575-582 (2001).
57. Naruhashi, K., Sai, Y., Tamai, I., Suzuki, N. & Tsuji, A. PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine. Pharm. Res. 19, 1417-1423 (2002).
58. Iakoubov, R., Ahmed, A., Lauffer, L. M., Bazinet, R. P. & Brubaker, P. L. Essential role for protein kinase Czeta in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat. Endocrinology 152, 1244-1252 (2011).
59. Shen, H., Smith, D. E. & Brosius, F. C. 3rd. Developmental expression of PEPT1 and PEPT2 in rat small intestine, colon, and kidney. Pediatr. Res. 49, 789-795 (2001).
60. Pan, X., Terada, T., Okuda, M. & Inui, K. The diurnal rhythm of the intestinal transporters SGLT1 and PEPT1 is regulated by the feeding conditions in rats. J. Nutr. 134, 2211-2215 (2004).
61. Thamotharan, M., Bawani, S. Z., Zhou, X. & Adibi, S. A. Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line. Am. J. Physiol. 276, C821-C826 (1999).
62. Buyse, M. et al. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J. Clin. Invest. 108, 1483-1494 (2001).
63. Ziegler, T. R. et al. Distribution of the H+/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome. Am. J. Clin. Nutr. 75, 922-930 (2002).
64. Hindlet, P. et al. Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation. J. Biol. Chem. 284, 6801-6808 (2009).
65. Richards, P. et al. High fat diet impairs the function of glucagon-like peptide-1 producing L-cells. Peptides 77, 21-27 (2016).
66. Watanabe, K., Terada, K. & Sato, J. Intestinal absorption of cephalexin in diabetes mellitus model rats. Eur. J. Pharm. Sci. 19, 91-98 (2003).
67. Gangopadhyay, A., Thamotharan, M. & Adibi, S. A. Regulation of oligopeptide transporter (Pept-1) in experimental diabetes. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G133-G138 (2002).
68. Buse, J. B. et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-Term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39, 198-205 (2016).
69. Zadeh-Tahmasebi, M. et al. Activation of short and long chain fatty acid sensing machinery in the ileum lowers glucose production in vivo. J. Biol. Chem. 291, 8816-8824 (2016).
70. Matthews, D. M., Muir, G. G. & Baron, D. N. Estimation of alpha-Amino nitrogen in plasma and urine by the colorimetric ninhydrin reaction. J. Clin. Pathol. 17, 150-153 (1964).